Tharimmune, Inc. financial data

Symbol
THAR on Nasdaq
Location
Bridgewater, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 182 % -59.4%
Debt-to-equity 123 % +326%
Return On Equity -588 % -251%
Return On Assets -264 % -103%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35M shares +2258%
Common Stock, Shares, Outstanding 7.21M shares +461%
Entity Public Float 1.7M USD -56.4%
Common Stock, Value, Issued 721 USD +459%
Weighted Average Number of Shares Outstanding, Basic 6.24M shares +303%
Weighted Average Number of Shares Outstanding, Diluted 6.24M shares +303%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.5M USD -33.9%
General and Administrative Expense 6.84M USD +17.5%
Operating Income (Loss) -10.3M USD +7%
Nonoperating Income (Expense) 19.6K USD -92.6%
Net Income (Loss) Attributable to Parent -10.3M USD +4.9%
Earnings Per Share, Basic -3 USD/shares +76.9%
Earnings Per Share, Diluted -3 USD/shares +76.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.61M USD +59.4%
Assets, Current 7.7M USD +46.6%
Assets 7.7M USD +46.6%
Accounts Payable, Current 659K USD -15.9%
Accrued Liabilities, Current 690K USD -49.6%
Liabilities, Current 1.54M USD -30.9%
Liabilities 1.54M USD -30.9%
Retained Earnings (Accumulated Deficit) -43.4M USD -31.2%
Stockholders' Equity Attributable to Parent 6.15M USD +104%
Liabilities and Equity 7.7M USD +46.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.69M USD +4.82%
Net Cash Provided by (Used in) Financing Activities 206K USD -35.2%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 7.21M shares +461%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.48M USD +0.98%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.61M USD +59.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.47K USD +80.2%
Deferred Tax Assets, Valuation Allowance 10.2M USD +52.6%
Deferred Tax Assets, Gross 10.2M USD +52.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 49.6M USD +37.2%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 1.52M USD +128%
Interest Expense 15.1K USD -23.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%